## LVS: Las Vegas Sands Corp. - XLY: Consumer Cyclical

### Executive Summary

VALUE thesis: PEG 0.89 indicates fundamental undervaluation. Quality metrics strong (ROE 66%). Consistent execution (3/4 quarters beat estimates).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($63.45)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 5, Bearish: 0)

**1. Las Vegas Sands (NYSE: LVS) shareholder files notice for 1.5M-share Rule 144 sale**
- Source: Stock Titan | 20251215T230903 | Neutral | Relevance: 100%
- A Las Vegas Sands (NYSE: LVS) shareholder, Robert G. Goldstein, has filed a Rule 144 notice to sell 1.5 million shares of common stock through Goldman Sachs & Co. LLC. The proposed sale has an aggregate market value of $100,485,000. These shares were acquired as compensation via stock options on December 15, 2025, using a cashless exercise and same-day sale structure, with previous sales by Goldstein also noted.

**2. Las Vegas Sands stock rating upgraded to Buy at Goldman Sachs**
- Source: Investing.com | 20251215T100837 | Bullish | Relevance: 100%
- Goldman Sachs upgraded Las Vegas Sands (NYSE:LVS) to Buy from Neutral, setting an $80 price target due to expected sustained momentum in Macau gaming revenue and strong performance at Marina Bay Sands. The firm expects Las Vegas Sands to maintain high EBITDA, engage in significant share repurchases, and invest in its IR2 project. This upgrade aligns with recent positive analyst updates following the company's stronger-than-expected third-quarter performance.

**3. Las Vegas Sands (NYSE:LVS) Rating Increased to Strong-Buy at Wall Street Zen**
- Source: MarketBeat | 20251213T065830 | Bullish | Relevance: 100%
- Wall Street Zen upgraded Las Vegas Sands (NYSE:LVS) to a "strong-buy" rating, with a consensus "Moderate Buy" from MarketBeat and an average target price of $65.80. This upgrade follows stronger-than-expected quarterly results, where the company reported $0.78 EPS against an expected $0.62 and $3.33 billion in revenue, marking a 24.2% year-over-year increase. Despite recent insider sales totaling approximately 3.1 million shares valued at $194.6 million, institutional investors have been increasing their positions in LVS.

**4. Chmn Goldstein Files To Sell 500,000 Of Las Vegas Sands Corp [LVS]**
- Source: TradingView | 20251213T020903 | Somewhat-Bearish | Relevance: 100%
- Robert G. Goldstein, Chairman of the Board of Las Vegas Sands Corp. (LVS), filed a Form 144 with the SEC on December 12, 2025, to sell 500,000 shares of restricted securities through Goldman Sachs & Co. This filing precedes the sale, allowing the owner to sell the shares within 90 days Of the filing date. The Washington Service, founded in 1970, provides financial, economic, and public policy research and data to securities professionals.

**5. Goldman Sachs Upgrades Las Vegas Sands to Buy From Neutral, Adjusts PT to $80 From $64**
- Source: marketscreener.com | 20251215T105137 | Bullish | Relevance: 100%
- Goldman Sachs has upgraded Las Vegas Sands (NYSE:LVS) to a "Buy" rating from "Neutral," significantly increasing its price target to $80 from $64. This upgrade indicates a more positive outlook for the casino and resorts operator. The article also provides recent insider transaction data and analyst recommendations from other firms.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 3, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-15 | Goldman Sachs | $80 | $64 | +25% |
| 2025-12-08 | UBS | $68 | $67 | +1% |
| 2025-12-01 | Argus Research | $80 | $65 | +23% |
| 2025-11-18 | Wells Fargo | $66 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-15 | Goldman Sachs | up | Buy |
| 2025-12-08 | UBS | main | Neutral |
| 2025-12-01 | Argus Research | main | Buy |
| 2025-11-18 | Wells Fargo | init | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 8 ($37.55M) |
| Sells | 8 ($47.01M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 24.9% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 2 / 8 |

**Top Holders:**
- Vanguard Group Inc: 6.2% (-2.0%)
- Capital Research Glo: 5.0% (-30.9%)
- Blackrock Inc.: 4.0% (-0.1%)
- Price (T.Rowe) Assoc: 2.2% (-7.8%)
- State Street Corpora: 2.1% (-7.2%)

### Key Risks

1. Heavy insider selling: $47M sold (8 transactions in 90 days).
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Analyst target momentum: 3 raises (avg +17%) could attract flows.
- Momentum building: MRS_20 improving +3.2% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 0.89 indicates undervaluation relative to growth. Forward P/E 21.1x stretched relative to 9% growth. Quality metrics strong (ROE 66%). Analyst sentiment positive (3 raises, avg +17%). Institutional flow bearish (8 selling vs 2 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $46.0B |
| Beta | 0.97 |
| 52W Range | $30.18 - $70.45 |
| Short Interest | 2.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.89 |
| Forward P/E | 21.1 |
| Current P/E | 23.1 |
| YoY Growth | 9.4% |
| EPS Direction | RISING |

### Technicals

MRS_20 strengthening from -2.0% to 1.2% (+3.2% in 5 days), confirming momentum buildup. Below STRENGTH zone by 2.8pp (needs >4.0% for momentum thesis). MRS_5 at 2.6% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram bearish (-0.51), momentum weakening. RSI neutral at 59. Elevated volume (1.6x 20MA), institutional activity likely. OFD pattern: -DBH (Indecision).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 1.21% (CS: 46) | Neutral |
| RSI_14 | 58.9 | Neutral |
| MACD Histogram | -0.51 | Bearish |
| vs SMA20 | 1.010x | Above |
| vs SMA50 | 1.105x | Above |
| vs SMA200 | 1.357x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $66.99
- **Stop Loss:** $63.45 (5.3% risk)
- **Target:** $74.07 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 338
- **Position Value:** $22,642.62
- **Portfolio %:** 22.64%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | MOMENTUM (Zone F) | 1.20x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at moderate levels (16.5) with elevated put/call ratio suggesting cautious positioning, while normal yield curve and stable breadth indicate no systemic stress. Focus on selective opportunities with defensive positioning.*

### Earnings

**Next:** 2026-01-28 (Est: $0.75)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.62 | $0.78 | +25.4% |
| 2025Q2 | $0.53 | $0.79 | +48.9% |
| 2025Q1 | $0.57 | $0.59 | +3.8% |
| 2024Q4 | $0.58 | $0.54 | -6.3% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*